Viewing Study NCT02446860


Ignite Creation Date: 2025-12-25 @ 2:16 AM
Ignite Modification Date: 2026-01-06 @ 11:32 PM
Study NCT ID: NCT02446860
Status: TERMINATED
Last Update Posted: 2025-06-06
First Post: 2015-03-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Anti-PD1 (Nivolumab) Therapy as Pre- and Post-operative Therapy in Metastatic Renal Cell Cancer (ADAPTeR)
Sponsor: Royal Marsden NHS Foundation Trust
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module